financetom
NUE
financetom
/
Materials
/
NUE
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Nucor CorporationNUE
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Nucor Corporation engages in manufacture and sale of steel and steel products.

The company's Steel Mills segment produces hot-rolled, cold-rolled, and galvanized sheet steel products; plate steel products; wide-flange beams, beam blanks, and H-piling and sheet piling products; and bar steel products, such as blooms, billets, concrete reinforcing and merchant bars, and engineered special bar quality products.

It also engages in the steel trading and rebar distribution businesses. This segment sells its products to steel service centers, fabricators, and manufacturers in the United States, Canada, and Mexico.

Its Steel Products segment offers hollow structural section steel tubing products, electrical conduits, steel racking, steel joists and joist girders, steel decks, fabricated concrete reinforcing steel products, cold finished steel products, steel fasteners, metal building systems, insulated metal panels, steel grating and expanded metal products, and wire and wire mesh products primarily for use in nonresidential construction applications.

This segment also engages in the piling distribution business. The company's Raw Materials segment produces direct reduced iron (DRI); brokers ferrous and nonferrous metals, pig iron, hot briquetted iron, and DRI; supplies ferro-alloys; and processes ferrous and nonferrous scrap metal.

This segment sells its ferrous scrap to electric arc furnace steel mills and foundries for manufacturing process; and nonferrous scrap metal to aluminum can producers, secondary aluminum smelters, steel mills and other processors, and consumers of various nonferrous metals.

It serves agriculture, automotive, construction, energy and transmission, oil and gas, heavy equipment, infrastructure, and transportation industries through its in-house sales force; and internal distribution and trading companies.

The company was founded in 1905 and is headquartered in Charlotte, North Carolina.

Latest News >
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
Aug 26, 2024
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for...
MoneyLion Authorizes $20 Million Stock Buyback Program
MoneyLion Authorizes $20 Million Stock Buyback Program
Aug 26, 2024
08:37 AM EDT, 08/26/2024 (MT Newswires) -- MoneyLion ( ML ) said Monday that its board has approved the repurchase of up to $20 million of its outstanding class A shares. The repurchase program, which has no fixed expiration date, is expected to be funded from existing cash on hand and future cash flows, the company said. Shares of MoneyLion...
MIRA Pharmaceuticals Shares Surge Pre-Bell on 'Significant' Ketamir-2 Study Data
MIRA Pharmaceuticals Shares Surge Pre-Bell on 'Significant' Ketamir-2 Study Data
Aug 26, 2024
08:36 AM EDT, 08/26/2024 (MT Newswires) -- MIRA Pharmaceuticals ( MIRA ) shares surged nearly 46% in Monday's premarket activity after reporting that a pre-clinical study in rats showed that its ketamine analog, Ketamir-2, resulted in a 100% normalization of pain thresholds at the highest dose. This effect stands in stark contrast to traditional ketamine, which proved ineffective orally under...
McKesson to buy controlling stake in Florida Cancer Specialists' unit for about $2.5 bln
McKesson to buy controlling stake in Florida Cancer Specialists' unit for about $2.5 bln
Aug 26, 2024
Aug 26 (Reuters) - Drug distributor McKesson said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's business and administrative services unit, Core Ventures, for $2.49 billion in cash. McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close...
Copyright 2023-2025 - www.financetom.com All Rights Reserved